At the news
? NEUTRALIMPACT 3/10 SC 13G filed Nov 10, 2026 at 09:34 ET
State Street Corp disclosed a 4.6% passive stake in Vera Therapeutics as of September 30, 2026, via a new Schedule 13G. This follows a prior 13G filing by State Street in August 2026, indicating a slight reduction from the earlier filing. The filing confirms passive intent with no activist purpose.
- State Street Corp filed a Schedule 13G disclosing beneficial ownership of 3,301,893 shares of Vera Therapeutics common stock as of September 30, 2026.
- The stake represents 4.6% of shares outstanding.
- State Street certifies the shares were acquired and are held in the ordinary course of business, with no intent to change or influence control.
- This is a new 13G filing by State Street; a prior 13G by State Street was filed on August 7, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access